{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:04:09Z","timestamp":1789974249535,"version":"4.0.1"},"reference-count":96,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:00:00Z","timestamp":1789862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:00:00Z","timestamp":1789862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["movementdisorders.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Movement Disord Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early\u2010onset hereditary spastic paraplegias (HSPs) are an underrecognized cause of progressive spasticity, gait impairment, and movement disorders in children and young adults. HSPs frequently mimic cerebral palsy or genetic, metabolic, and acquired disorders, resulting in diagnostic delay. Their broad phenotypic spectrum, encompassing dystonia, parkinsonism, and neurodevelopmental features, makes them highly relevant to movement disorder practitioners across the lifespan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This review summarizes the phenotypic spectrum of early\u2010onset HSP, outlines a practical diagnostic approach for clinicians, and discusses therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a narrative review of PubMed\u2010indexed literature through February 2026, supplemented by expert consensus. HSPs typically presenting in childhood and adolescence, inclusive of forms presenting across a broader age spectrum, with attention to subtypes presenting with movement disorders, were considered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Early\u2010onset HSPs encompass both pure and complex forms, with SPG4 (\n                      <jats:italic>SPAST<\/jats:italic>\n                      ) and SPG11 (\n                      <jats:italic>SPG11\/KIAA1840<\/jats:italic>\n                      ) among the most prevalent etiologies. Diagnostic challenges include distinction from cerebral palsy and other movement disorders including dopa\u2010responsive dystonia, and identification of neuroimaging signatures in specific subtypes. A multidisciplinary management approach remains central, with spasticity, movement disorder, and neurological comorbidities each requiring targeted consideration. Disease\u2010modifying therapies are emerging, including gene replacement strategies and antisense oligonucleotide approaches for select subtypes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Early\u2010onset HSPs represent a clinically and genetically heterogeneous group with substantial overlap with movement disorder practice. Awareness of characteristic phenotypes, early genetic testing, and an individualized multidisciplinary approach are essential. Recent advances in natural history characterization and mechanism\u2010targeted therapeutics signal a transition toward disease\u2010modifying treatment strategies and offer cautious optimism for affected individuals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/mdc3.70827","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:41:21Z","timestamp":1789972881000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phenotypic Spectrum and Clinical Approach to Early\u2010Onset Hereditary Spastic Paraplegia"],"prefix":"10.1002","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6677-869X","authenticated-orcid":false,"given":"Jenny L.","family":"Wilson","sequence":"first","affiliation":[{"name":"Division of Pediatric Neurology Oregon Health &amp; Science University  Portland Oregon USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1261-9655","authenticated-orcid":false,"given":"Craig","family":"Blackstone","sequence":"additional","affiliation":[{"name":"Department of Neurology Massachusetts General Hospital and Harvard Medical School  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0026-4714","authenticated-orcid":false,"given":"Darius","family":"Ebrahimi\u2010Fakhari","sequence":"additional","affiliation":[{"name":"Movement Disorders Program, Department of Neurology Boston Children's Hospital and Harvard Medical School  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0898-2419","authenticated-orcid":false,"given":"Marcondes C.","family":"Fran\u00e7a Junior","sequence":"additional","affiliation":[{"name":"Departamento de Neurologia Universidade Estadual de Campinas  Campinas Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,20]]},"reference":[{"issue":"3","key":"e_1_2_16_2_1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000358801","article-title":"The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies","volume":"42","author":"Ruano L","year":"2014","journal-title":"Neuroepidemiology"},{"key":"e_1_2_16_3_1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/B978-0-444-64076-5.00041-7","article-title":"Hereditary spastic paraplegia","volume":"148","author":"Blackstone C","year":"2018","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"e_1_2_16_4_1","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70260","article-title":"Neurodevelopmental implications underpinning hereditary spastic paraplegia","volume":"31","author":"Zhi Y","year":"2025","journal-title":"CNS Neurosci Ther"},{"issue":"9","key":"e_1_2_16_5_1","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/dmcn.14547","article-title":"Paediatric\u2010onset hereditary spastic paraplegias: a retrospective cohort study","volume":"62","author":"Schiavoni S","year":"2020","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"e_1_2_16_6_1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/dmcn.15385","article-title":"Clinical and genetic spectrum of hereditary spastic paraplegia in Chinese children","volume":"65","author":"Wang J","year":"2023","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"e_1_2_16_7_1","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200249","article-title":"The spastic paraplegia\u2010centers of excellence research network (SP\u2010CERN): clinical trial readiness for hereditary spastic paraplegia","volume":"11","author":"Schierbaum L","year":"2025","journal-title":"Neurol Genet"},{"issue":"1","key":"e_1_2_16_8_1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/hmg\/ddac182","article-title":"De novo variants cause complex symptoms in HSP\u2010ATL1 (SPG3A) and uncover genotype\u2010phenotype correlations","volume":"32","author":"Alecu JE","year":"2023","journal-title":"Hum Mol Genet"},{"issue":"10","key":"e_1_2_16_9_1","first-page":"2929","article-title":"Defining the clinical, molecular and imaging spectrum of adaptor protein complex 4\u2010associated hereditary spastic paraplegia","volume":"143","author":"Ebrahimi\u2010Fakhari D","year":"2020","journal-title":"Brain"},{"issue":"12","key":"e_1_2_16_10_1","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1002\/mds.29225","article-title":"Early\u2010onset and severe complex hereditary spastic paraplegia caused by De novo variants in SPAST","volume":"37","author":"Mo A","year":"2022","journal-title":"Mov Disord"},{"issue":"3","key":"e_1_2_16_11_1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/mds.70141","article-title":"Spectrum of movement disorders in early\u2010onset hereditary spastic paraplegia: a study of 428 cases","volume":"41","author":"Resch D","year":"2025","journal-title":"Mov Disord"},{"issue":"5","key":"e_1_2_16_12_1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/mds.29384","article-title":"Reply to: early\u2010onset and severe complex hereditary spastic paraplegia caused by De novo variants in SPAST","volume":"38","author":"Saffari A","year":"2023","journal-title":"Mov Disord"},{"issue":"5","key":"e_1_2_16_13_1","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/brain\/awac391","article-title":"The clinical and molecular spectrum of ZFYVE26\u2010associated hereditary spastic paraplegia: SPG15","volume":"146","author":"Saffari A","year":"2023","journal-title":"Brain"},{"issue":"1","key":"e_1_2_16_14_1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/acn3.70244","article-title":"Health\u2010related quality of life in rare forms of childhood\u2010onset hereditary spastic paraplegia","volume":"13","author":"Schmidt HJD","year":"2026","journal-title":"Ann Clin Transl Neurol"},{"key":"e_1_2_16_15_1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pediatrneurol.2024.01.005","article-title":"A retrospective review of 18 patients with childhood\u2010onset hereditary spastic paraplegia, nine with novel variants","volume":"152","author":"Kilic MA","year":"2024","journal-title":"Pediatr Neurol"},{"key":"e_1_2_16_16_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pediatrneurol.2022.02.007","article-title":"Childhood\u2010onset hereditary spastic paraplegia (HSP): a case series and review of literature","volume":"130","author":"Panwala TF","year":"2022","journal-title":"Pediatr Neurol"},{"issue":"4","key":"e_1_2_16_17_1","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ymgme.2021.06.006","article-title":"Childhood\u2010onset hereditary spastic paraplegia and its treatable mimics","volume":"137","author":"Ebrahimi\u2010Fakhari D","year":"2022","journal-title":"Mol Genet Metab"},{"issue":"1","key":"e_1_2_16_18_1","doi-asserted-by":"crossref","first-page":"22248","DOI":"10.1038\/s41598-021-01635-2","article-title":"Clinical and molecular characterization of a large cohort of childhood onset hereditary spastic paraplegias","volume":"11","author":"Giordani GM","year":"2021","journal-title":"Sci Rep"},{"key":"e_1_2_16_19_1","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.nicl.2018.05.031","article-title":"SPG11 mutations cause widespread white matter and basal ganglia abnormalities, but restricted cortical damage","volume":"19","author":"Faber I","year":"2018","journal-title":"Neuroimage Clin"},{"issue":"2","key":"e_1_2_16_20_1","doi-asserted-by":"crossref","first-page":"E376","DOI":"10.1002\/humu.20920","article-title":"Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10","volume":"30","author":"Goizet C","year":"2009","journal-title":"Hum Mutat"},{"issue":"6","key":"e_1_2_16_21_1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/ejhg.2011.261","article-title":"KIF1A missense mutations in SPG30, an autosomal recessive spastic paraplegia: distinct phenotypes according to the nature of the mutations","volume":"20","author":"Klebe S","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"e_1_2_16_22_1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clineuro.2018.02.042","article-title":"Novel homozygous GBA2 mutation in a patient with complicated spastic paraplegia","volume":"168","author":"Coarelli G","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"key":"e_1_2_16_23_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.116620","article-title":"Ophthalmological changes in hereditary spastic paraplegia and other genetic diseases with spastic paraplegia","volume":"409","author":"Freitas JL","year":"2020","journal-title":"J Neurol Sci"},{"issue":"1","key":"e_1_2_16_24_1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13052-019-0752-5","article-title":"Long\u2010term follow\u2010up until early adulthood in autosomal dominant, complex SPG30 with a novel KIF1A variant: a case report","volume":"45","author":"Spagnoli C","year":"2019","journal-title":"Ital J Pediatr"},{"issue":"1","key":"e_1_2_16_25_1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/nyas.14229","article-title":"Dwarfism in Troyer syndrome: a family with SPG20 compound heterozygous mutations and a literature review","volume":"1462","author":"Liang H","year":"2020","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"e_1_2_16_26_1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ajmg.1320570122","article-title":"Spectrum of X\u2010linked hydrocephalus (HSAS), MASA syndrome, and complicated spastic paraplegia (SPG1): clinical review with six additional families","volume":"57","author":"Schrander\u2010Stumpel C","year":"1995","journal-title":"Am J Med Genet"},{"key":"e_1_2_16_27_1","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1226479","article-title":"Long\u2010term progression of clinician\u2010reported and gait performance outcomes in hereditary spastic paraplegias","volume":"17","author":"Cubillos Arcila DM","year":"2023","journal-title":"Front Neurosci"},{"issue":"6","key":"e_1_2_16_28_1","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2990.2004.00587.x","article-title":"The extent of axonal loss in the long tracts in hereditary spastic paraplegia","volume":"30","author":"Deluca GC","year":"2004","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"e_1_2_16_29_1","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/brain\/awac155","article-title":"The prodromal phase of hereditary spastic paraplegia type 4: the preSPG4 cohort study","volume":"146","author":"Rattay TW","year":"2023","journal-title":"Brain"},{"issue":"19","key":"e_1_2_16_30_1","doi-asserted-by":"crossref","first-page":"e1942","DOI":"10.1212\/WNL.0000000000012836","article-title":"Systematic analysis of brain MRI findings in adaptor protein complex 4\u2010associated hereditary spastic paraplegia","volume":"97","author":"Ebrahimi\u2010Fakhari D","year":"2021","journal-title":"Neurology"},{"issue":"3","key":"e_1_2_16_31_1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/cns3.70035","article-title":"Fetal and perinatal brain MRI findings in adaptor protein complex 4\u2013associated hereditary spastic paraplegia","volume":"3","author":"Brooks AK","year":"2025","journal-title":"Ann Child Neurol Soc"},{"issue":"9","key":"e_1_2_16_32_1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00415-025-13251-5","article-title":"Spinal cord structural changes in SPG4: insights from a large cohort using advanced neuroimaging","volume":"272","author":"Gonz\u00e1lez\u2010Salazar C","year":"2025","journal-title":"J Neurol"},{"issue":"2","key":"e_1_2_16_33_1","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000664","article-title":"Clinical\u2010genetic features influencing disability in spastic paraplegia type 4: a cross\u2010sectional study by the Italian DAISY network","volume":"8","author":"Rossi S","year":"2022","journal-title":"Neurol Genet"},{"issue":"4","key":"e_1_2_16_34_1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamaneurol.2013.1956","article-title":"Autosomal dominant spastic paraplegias: a review of 89 families resulting from a portuguese survey","volume":"70","author":"Loureiro JL","year":"2013","journal-title":"JAMA Neurol"},{"key":"e_1_2_16_35_1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3389\/fneur.2018.01117","article-title":"Neuroimaging in hereditary spastic paraplegias: current use and future perspectives","volume":"9","author":"Gra\u00e7a FF","year":"2018","journal-title":"Front Neurol"},{"issue":"7","key":"e_1_2_16_36_1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/14737159.2022.2118048","article-title":"Neuroimaging in hereditary spastic paraplegias: from qualitative cues to precision biomarkers","volume":"22","author":"Mulkerrin G","year":"2022","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"e_1_2_16_37_1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3174\/ajnr.A5935","article-title":"\u201cEars of the lynx\u201d MRI sign is associated with SPG11 and SPG15 hereditary spastic paraplegia","volume":"40","author":"Pascual B","year":"2019","journal-title":"AJNR Am J Neuroradiol"},{"issue":"11","key":"e_1_2_16_38_1","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/jama.288.11.1357","article-title":"Prognosis for gross motor function in cerebral palsy: creation of motor development curves","volume":"288","author":"Rosenbaum PL","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"e_1_2_16_39_1","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.gaitpost.2011.01.009","article-title":"Gait analysis may help to distinguish hereditary spastic paraplegia from cerebral palsy","volume":"33","author":"Wolf SI","year":"2011","journal-title":"Gait Posture"},{"issue":"2","key":"e_1_2_16_40_1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ejpn.2018.12.004","article-title":"SLC2A1 mutations are a rare cause of pediatric\u2010onset hereditary spastic paraplegia","volume":"23","author":"Nicita F","year":"2019","journal-title":"Eur J Paediatr Neurol"},{"key":"e_1_2_16_41_1","article-title":"Single\u2010center experience with Beta\u2010propeller protein\u2010associated neurodegeneration (BPAN); expanding the phenotypic spectrum","volume":"20","author":"Chard M","year":"2019","journal-title":"Mol Genet Metab Rep"},{"issue":"5","key":"e_1_2_16_42_1","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/cge.13008","article-title":"PLA2G6 mutations associated with a continuous clinical spectrum from neuroaxonal dystrophy to hereditary spastic paraplegia","volume":"92","author":"Ozes B","year":"2017","journal-title":"Clin Genet"},{"issue":"8","key":"e_1_2_16_43_1","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/humu.23554","article-title":"Autosomal\u2010dominant early\u2010onset spastic paraparesis with brain calcification due to IFIH1 gain\u2010of\u2010function","volume":"39","author":"Ruaud L","year":"2018","journal-title":"Hum Mutat"},{"issue":"2","key":"e_1_2_16_44_1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/0956462420933786","article-title":"HIV\u2010vacuolar myelopathy: an unusual early presentation in HIV","volume":"32","author":"Leffert J","year":"2021","journal-title":"Int J STD AIDS"},{"issue":"6","key":"e_1_2_16_45_1","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9060450","article-title":"Early\u2010onset HTLV\u20101\u2010associated myelopathy\/tropical spastic Paraparesis","volume":"9","author":"Schwalb A","year":"2020","journal-title":"Pathogens"},{"issue":"1","key":"e_1_2_16_46_1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.braindev.2018.07.006","article-title":"A case of subacute combined degeneration of the spinal cord due to folic acid and copper deficiency","volume":"41","author":"Nakamura T","year":"2019","journal-title":"Brain Dev"},{"issue":"12","key":"e_1_2_16_47_1","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S1474-4422(19)30235-2","article-title":"Hereditary spastic paraplegia: from diagnosis to emerging therapeutic approaches","volume":"18","author":"Shribman S","year":"2019","journal-title":"Lancet Neurol"},{"issue":"3","key":"e_1_2_16_48_1","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/brain\/awab386","article-title":"Clinical and genetic spectra of 1550 index patients with hereditary spastic paraplegia","volume":"145","author":"M\u00e9reaux JL","year":"2022","journal-title":"Brain"},{"issue":"11","key":"e_1_2_16_49_1","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1038\/s41436-019-0554-6","article-title":"Meta\u2010analysis and multidisciplinary consensus statement: exome sequencing is a first\u2010tier clinical diagnostic test for individuals with neurodevelopmental disorders","volume":"21","author":"Srivastava S","year":"2019","journal-title":"Genet Med"},{"issue":"11","key":"e_1_2_16_50_1","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1111\/ene.14405","article-title":"Deciphering the natural history of SCA7 in children","volume":"27","author":"Bah MG","year":"2020","journal-title":"Eur J Neurol"},{"key":"e_1_2_16_51_1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.clineuro.2018.06.037","article-title":"Spastic paraparesis as the first manifestation of Machado\u2010Joseph disease: a case report and review of the literature","volume":"172","author":"Lin HC","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"e_1_2_16_52_1","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1590\/S0004-282X2008000200021","article-title":"Spastic paraparesis as the onset manifestation of spinocerebellar ataxia type 7","volume":"66","author":"Linhares SC","year":"2008","journal-title":"Arq Neuropsiquiatr"},{"issue":"3","key":"e_1_2_16_53_1","first-page":"846","article-title":"Machado\u2010Joseph disease: a proposal of spastic paraplegic subtype","volume":"46","author":"Sakai T","year":"1996","journal-title":"Neurology"},{"issue":"23","key":"e_1_2_16_54_1","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020193","article-title":"Genetic mutation analysis of hereditary spastic paraplegia: a retrospective study","volume":"99","author":"Cui F","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"e_1_2_16_55_1","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awag050","article-title":"Diagnostic yield of genome sequencing in children with progressive movement disorders","author":"Schierbaum L","year":"2026","journal-title":"Brain"},{"issue":"5","key":"e_1_2_16_56_1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1017\/cjn.2021.188","article-title":"Anticipation can Be more common in hereditary spastic paraplegia with SPAST mutations than it appears","volume":"49","author":"Hashemi SS","year":"2022","journal-title":"Can J Neurol Sci"},{"issue":"2","key":"e_1_2_16_57_1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1017\/S0317167100006053","article-title":"Possible anticipation in hereditary spastic paraplegia type 4 (SPG4)","volume":"34","author":"Reddy PL","year":"2007","journal-title":"Can J Neurol Sci"},{"issue":"3","key":"e_1_2_16_58_1","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1542\/peds.2012-3680","article-title":"Ethical and policy issues in genetic testing and screening of children","volume":"131","year":"2013","journal-title":"Pediatrics"},{"issue":"5","key":"e_1_2_16_59_1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2340\/16501977-2227","article-title":"Pathophysiology, diagnostic work\u2010up and management of balance impairments and falls in patients with hereditary spastic paraplegia","volume":"49","author":"Nonnekes J","year":"2017","journal-title":"J Rehabil Med"},{"issue":"6","key":"e_1_2_16_60_1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1468-1331.2007.01812.x","article-title":"Double\u2010blind crossover trial of gabapentin in SPG4\u2010linked hereditary spastic paraplegia","volume":"14","author":"Scheuer KH","year":"2007","journal-title":"Eur J Neurol"},{"key":"e_1_2_16_61_1","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1256392","article-title":"Gait analysis patterns and rehabilitative interventions to improve gait in persons with hereditary spastic paraplegia: a systematic review and meta\u2010analysis","volume":"14","author":"Faccioli S","year":"2023","journal-title":"Front Neurol"},{"issue":"8","key":"e_1_2_16_62_1","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1177\/0883073809356037","article-title":"Botulinum toxin injections for pediatric patients with hereditary spastic paraparesis","volume":"25","author":"Geva\u2010Dayan K","year":"2010","journal-title":"J Child Neurol"},{"issue":"2","key":"e_1_2_16_63_1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1469-8749.2009.03583.x","article-title":"Systemic adverse events following botulinum toxin a therapy in children with cerebral palsy","volume":"52","author":"Naidu K","year":"2010","journal-title":"Dev Med Child Neurol"},{"issue":"11","key":"e_1_2_16_64_1","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/dmcn.13995","article-title":"Systemic adverse events after botulinum neurotoxin a injections in children with cerebral palsy","volume":"60","author":"Paget SP","year":"2018","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"e_1_2_16_65_1","doi-asserted-by":"crossref","DOI":"10.3390\/toxins14020139","article-title":"Reduced cross\u2010sectional muscle growth six months after botulinum toxin type\u2010a injection in children with spastic cerebral palsy","volume":"14","author":"De Beukelaer N","year":"2022","journal-title":"Toxins (Basel)"},{"key":"e_1_2_16_66_1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejpn.2021.11.003","article-title":"The use of intrathecal baclofen for management of spasticity in hereditary spastic paraparesis: a case series","volume":"36","author":"Pointon R","year":"2022","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"e_1_2_16_67_1","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00381-023-06159-w","article-title":"Surgical treatment options for spasticity in children and adolescents with hereditary spastic paraplegia","volume":"40","author":"Pol LA","year":"2024","journal-title":"Childs Nerv Syst"},{"issue":"1","key":"e_1_2_16_68_1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/BPO.0b013e3181c6b257","article-title":"Complications of intrathecal baclofen pump therapy in pediatric patients","volume":"30","author":"Borowski A","year":"2010","journal-title":"J Pediatr Orthop"},{"issue":"6","key":"e_1_2_16_69_1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3171\/2024.6.PEDS23360","article-title":"Complications of intrathecal baclofen therapy in children and young adults","volume":"34","author":"Ryan MV","year":"2024","journal-title":"J Neurosurg Pediatr"},{"key":"e_1_2_16_70_1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-3-031-86441-4_6","article-title":"Selection of children with spasticity other than cerebral palsy: indications, long\u2010term outcome, and exclusion criteria","volume":"51","author":"Kakodkar P","year":"2025","journal-title":"Adv Tech Stand Neurosurg"},{"issue":"9","key":"e_1_2_16_71_1","article-title":"Selective dorsal Rhizotomy for treatment of hereditary spastic paraplegia\u2010associated spasticity in 37 patients","volume":"13","author":"Park TS","year":"2021","journal-title":"Cureus"},{"issue":"8","key":"e_1_2_16_72_1","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00381-016-3122-2","article-title":"Selective dorsal rhizotomy for hereditary spastic paraparesis in children","volume":"32","author":"Sharma J","year":"2016","journal-title":"Childs Nerv Syst"},{"issue":"2","key":"e_1_2_16_73_1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3171\/2025.2.PEDS24576","article-title":"Intrathecal baclofen pump versus combined dorsal\/ventral rhizotomy for spastic quadriplegia: healthcare cost and complication analysis","volume":"36","author":"Hartman E","year":"2025","journal-title":"J Neurosurg Pediatr"},{"key":"e_1_2_16_74_1","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00003","article-title":"Management of Hereditary Spastic Paraplegia: a systematic review of the literature","volume":"10","author":"Bellofatto M","year":"2019","journal-title":"Front Neurol"},{"issue":"9","key":"e_1_2_16_75_1","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1007\/s00415-013-7044-6","article-title":"Exome sequencing expands the mutational spectrum of SPG8 in a family with spasticity responsive to L\u2010DOPA treatment","volume":"260","author":"Bettencourt C","year":"2013","journal-title":"J Neurol"},{"issue":"8","key":"e_1_2_16_76_1","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/mdc3.13815","article-title":"Spastic paraplegia type 30 associated with levodopa\u2010responsive parkinsonism","volume":"10","author":"Gallagher A","year":"2023","journal-title":"Mov Disord Clin Pract"},{"key":"e_1_2_16_77_1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.parkreldis.2017.12.004","article-title":"SPG7 with parkinsonism responsive to levodopa and dopaminergic deficit","volume":"47","author":"Pedroso JL","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"e_1_2_16_78_1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1001\/jamaneurol.2016.4297","article-title":"Pallidal deep brain stimulation for the treatment of levodopa\u2010responsive juvenile dystonia and parkinsonism secondary to SPG11 mutation","volume":"74","author":"Ramirez\u2010Zamora A","year":"2017","journal-title":"JAMA Neurol"},{"issue":"5","key":"e_1_2_16_79_1","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00415-015-7707-6","article-title":"Dalfampridine in hereditary spastic paraplegia: a prospective, open study","volume":"262","author":"B\u00e9reau M","year":"2015","journal-title":"J Neurol"},{"issue":"3","key":"e_1_2_16_80_1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000449375","article-title":"The effects of Dalfampridine on hereditary spastic Paraparesis","volume":"76","author":"Uygunoglu U","year":"2016","journal-title":"Eur Neurol"},{"key":"e_1_2_16_81_1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jocn.2023.09.026","article-title":"Dalfampridine as a promising agent in the management of hereditary spastic paraplegia: a triple\u2010blinded, randomized, placebo\u2010controlled pilot trial","volume":"117","author":"Selcuk Muhtaroglu F","year":"2023","journal-title":"J Clin Neurosci"},{"key":"e_1_2_16_82_1","volume-title":"GeneReviews(\u00ae)","author":"Alecu J","year":"1993"},{"issue":"4","key":"e_1_2_16_83_1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/ene.13878","article-title":"Autonomic dysfunction in hereditary spastic paraplegia type 4","volume":"26","author":"Gonz\u00e1lez\u2010Salazar C","year":"2019","journal-title":"Eur J Neurol"},{"issue":"2","key":"e_1_2_16_84_1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00415-019-09573-w","article-title":"Non\u2010motor symptoms are relevant and possibly treatable in hereditary spastic paraplegia type 4 (SPG4)","volume":"267","author":"Rattay TW","year":"2020","journal-title":"J Neurol"},{"issue":"1","key":"e_1_2_16_85_1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000097007","article-title":"Restless legs syndrome in hereditary spastic paraparesis","volume":"57","author":"Sperfeld AD","year":"2007","journal-title":"Eur Neurol"},{"issue":"10","key":"e_1_2_16_86_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104138","article-title":"Preclinical alternative drug discovery programs for monogenic rare diseases. Should small molecules or gene therapy be used? The case of hereditary spastic paraplegias","volume":"29","author":"Sebastiano MR","year":"2024","journal-title":"Drug Discov Today"},{"issue":"2","key":"e_1_2_16_87_1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/hmg\/ddz310","article-title":"Adaptor protein complex 4 deficiency: a paradigm of childhood\u2010onset hereditary spastic paraplegia caused by defective protein trafficking","volume":"29","author":"Behne R","year":"2020","journal-title":"Hum Mol Genet"},{"issue":"18","key":"e_1_2_16_88_1","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single\u2010dose gene\u2010replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell JR","year":"2017","journal-title":"N Engl J Med"},{"issue":"12","key":"e_1_2_16_89_1","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide Tofersen for SOD1 ALS","volume":"387","author":"Miller TM","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"e_1_2_16_90_1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/brain\/awx297","article-title":"Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5","volume":"141","author":"Marelli C","year":"2018","journal-title":"Brain"},{"issue":"7","key":"e_1_2_16_91_1","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/jamaneurol.2014.116","article-title":"Severe methylenetetrahydrofolate reductase deficiency: clinical clues to a potentially treatable cause of adult\u2010onset hereditary spastic paraplegia","volume":"71","author":"Lossos A","year":"2014","journal-title":"JAMA Neurol"},{"issue":"3","key":"e_1_2_16_92_1","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/ene.13557","article-title":"Severe 5,10\u2010methylenetetrahydrofolate reductase deficiency: a rare, treatable cause of complicated hereditary spastic paraplegia","volume":"25","author":"Perna A","year":"2018","journal-title":"Eur J Neurol"},{"key":"e_1_2_16_93_1","article-title":"CYP2U1: an emerging treatable neurometabolic disease with cerebral folate deficiency in 2 Chinese brothers","volume":"38","author":"Wong SS","year":"2024","journal-title":"Mol Genet Metab Rep"},{"issue":"11","key":"e_1_2_16_94_1","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210846","article-title":"Implication of folate deficiency in CYP2U1 loss of function","volume":"218","author":"Pujol C","year":"2021","journal-title":"J Exp Med"},{"issue":"7","key":"e_1_2_16_95_1","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1038\/s41591-024-03078-4","article-title":"AAV gene therapy for hereditary spastic paraplegia type 50: a phase 1 trial in a single patient","volume":"30","author":"Dowling JJ","year":"2024","journal-title":"Nat Med"},{"issue":"11","key":"e_1_2_16_96_1","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1038\/s44321-024-00148-5","article-title":"Pre\u2010clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47","volume":"16","author":"Wiseman JP","year":"2024","journal-title":"EMBO Mol Med"},{"issue":"10","key":"e_1_2_16_97_1","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1038\/s41591-024-03197-y","article-title":"Antisense oligonucleotide therapy in an individual with KIF1A\u2010associated neurological disorder","volume":"30","author":"Ziegler A","year":"2024","journal-title":"Nat Med"}],"container-title":["Movement Disorders Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mdc3.70827","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/mdc3.70827","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mdc3.70827","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:41:35Z","timestamp":1789972895000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mdc3.70827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,20]]},"references-count":96,"alternative-id":["10.1002\/mdc3.70827"],"URL":"https:\/\/doi.org\/10.1002\/mdc3.70827","archive":["Portico"],"relation":{},"ISSN":["2330-1619","2330-1619"],"issn-type":[{"value":"2330-1619","type":"print"},{"value":"2330-1619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,20]]},"assertion":[{"value":"2026-05-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"mdc3.70827"}}